The FINANCIAL -- Researchers from Bayer CropScience are the first to have successfully incorporated deltamethrin, its WHO-recommended active ING redient, into polypropylene fiber.

The FINANCIAL -- Johnson & Johnson on November 3 announced global restructuring initiatives designed to strengthen the company’s position as the world’s leading global health care company. 

The FINANCIAL -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) on November 3 reported results for the quarter ended September 30, 2009.

The FINANCIAL -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced on November 2 a number of changes to its Executive Committee. In a message to employees, Christopher A. Viehbacher, Chief Executive Officer of sanofi-aventis, detailed the new appointments and his new management team.

The FINANCIAL -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Takeda Pharmaceutical Company Limited (TSE: 4502) announced on November 2 that they have entered into a worldwide exclusive license, development and commercialization agreement to co-develop and commercialize pharmaceutical products for the treatment of obesity and related indications.